{ "company_number": "07133146", "name": "COX Pharmaceutical Ltd", "url": "/company/07133146", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2010-01-22", "dissolved_on": null, "sic_codes": [ { "code": "21100", "description": "Manufacture of basic pharmaceutical products", "section": "C", "section_name": "Manufacturing", "url": "/sic/21100" } ], "registered_address": { "id": 937069, "url": "/address/937069", "line1": "ELSCOT HOUSE", "line2": "ARCADIA AVENUE", "post_town": "LONDON", "county": "", "country": "UNITED KINGDOM", "postcode": "N3 2JU" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07133146", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-10-31", "last_made_up": "2025-01-31", "category": "MICRO ENTITY", "filings": [ { "url": "/company/07133146/accounts/2025-01-31", "pdf_url": "/company/07133146/accounts/2025-01-31.pdf", "made_up_date": "2025-01-31", "period_start": "2025-01-31", "period_end": "2025-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "374422.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "335976.00", "total_assets_less_current_liabilities": "335976.00", "net_assets_liabilities": "1985625.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1985625.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2025.zip" }, { "url": "/company/07133146/accounts/2024-01-31", "pdf_url": "/company/07133146/accounts/2024-01-31.pdf", "made_up_date": "2024-01-31", "period_start": "2024-01-31", "period_end": "2024-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "364059.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "321592.00", "total_assets_less_current_liabilities": "321592.00", "net_assets_liabilities": "2000009.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2000009.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2024.zip" }, { "url": "/company/07133146/accounts/2023-01-31", "pdf_url": "/company/07133146/accounts/2023-01-31.pdf", "made_up_date": "2023-01-31", "period_start": "2023-01-31", "period_end": "2023-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "347415.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "304948.00", "total_assets_less_current_liabilities": "304948.00", "net_assets_liabilities": "2136922.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2136922.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2023.zip" }, { "url": "/company/07133146/accounts/2022-01-31", "pdf_url": "/company/07133146/accounts/2022-01-31.pdf", "made_up_date": "2022-01-31", "period_start": "2022-01-31", "period_end": "2022-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "359471.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "317587.00", "total_assets_less_current_liabilities": "317587.00", "net_assets_liabilities": "2083283.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2083283.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2022.zip" }, { "url": "/company/07133146/accounts/2021-01-31", "pdf_url": "/company/07133146/accounts/2021-01-31.pdf", "made_up_date": "2021-01-31", "period_start": "2021-01-31", "period_end": "2021-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "362.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "342598.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "300714.00", "total_assets_less_current_liabilities": "301076.00", "net_assets_liabilities": "2099794.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2099794.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/07133146/accounts/2020-01-31", "pdf_url": "/company/07133146/accounts/2020-01-31.pdf", "made_up_date": "2020-01-31", "period_start": "2020-01-31", "period_end": "2020-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "3184.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "412870.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "371118.00", "total_assets_less_current_liabilities": "374302.00", "net_assets_liabilities": "2026568.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "2026568.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2021.zip" }, { "url": "/company/07133146/accounts/2019-01-31", "pdf_url": "/company/07133146/accounts/2019-01-31.pdf", "made_up_date": "2019-01-31", "period_start": "2019-01-31", "period_end": "2019-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "9485.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "521739.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "482658.00", "total_assets_less_current_liabilities": "492143.00", "net_assets_liabilities": "1797660.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1797660.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2019.zip" }, { "url": "/company/07133146/accounts/2018-01-31", "pdf_url": "/company/07133146/accounts/2018-01-31.pdf", "made_up_date": "2018-01-31", "period_start": "2018-01-31", "period_end": "2018-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "13190.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "509324.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "478953.00", "total_assets_less_current_liabilities": "492143.00", "net_assets_liabilities": "1576995.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1576995.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/07133146/accounts/2017-01-31", "pdf_url": "/company/07133146/accounts/2017-01-31.pdf", "made_up_date": "2017-01-31", "period_start": "2017-01-31", "period_end": "2017-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "14970.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "528860.00", "creditors_due_within_one_year": "25831.00", "creditors_due_after_one_year": "1849137.00", "net_current_assets_liabilities": "503029.00", "total_assets_less_current_liabilities": "517999.00", "net_assets_liabilities": "-1331138.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-1331138.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2017.zip" }, { "url": "/company/07133146/accounts/2016-01-31", "pdf_url": "/company/07133146/accounts/2016-01-31.pdf", "made_up_date": "2016-01-31", "period_start": "2016-01-31", "period_end": "2016-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "238087.00", "cash_bank_in_hand": "47313.00", "current_assets": "637784.00", "creditors_due_within_one_year": "25831.00", "creditors_due_after_one_year": "1704137.00", "net_current_assets_liabilities": "611953.00", "total_assets_less_current_liabilities": "611953.00", "net_assets_liabilities": "-1092184.00", "called_up_share_capital": "10000.00", "profit_loss_account_reserve": "-1102184.00", "shareholder_funds": "-1092184.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2016.zip" }, { "url": "/company/07133146/accounts/2015-01-31", "pdf_url": "/company/07133146/accounts/2015-01-31.pdf", "made_up_date": "2015-01-31", "period_start": "2015-01-31", "period_end": "2015-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "281628.00", "cash_bank_in_hand": "33844.00", "current_assets": "776792.00", "creditors_due_within_one_year": "20570.00", "creditors_due_after_one_year": "1023419.00", "net_current_assets_liabilities": "756222.00", "total_assets_less_current_liabilities": "756222.00", "net_assets_liabilities": "-267197.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-267198.00", "shareholder_funds": "-267197.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2015.zip" }, { "url": "/company/07133146/accounts/2014-01-31", "pdf_url": "/company/07133146/accounts/2014-01-31.pdf", "made_up_date": "2014-01-31", "period_start": "2014-01-31", "period_end": "2014-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "69420.00", "current_assets": "530740.00", "creditors_due_within_one_year": "20570.00", "creditors_due_after_one_year": "844159.00", "net_current_assets_liabilities": "510170.00", "total_assets_less_current_liabilities": "510170.00", "net_assets_liabilities": "-333989.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-333990.00", "shareholder_funds": "-333989.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2014.zip" }, { "url": "/company/07133146/accounts/2013-01-31", "pdf_url": "/company/07133146/accounts/2013-01-31.pdf", "made_up_date": "2013-01-31", "period_start": "2013-01-31", "period_end": "2013-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "3815.00", "current_assets": "465135.00", "creditors_due_within_one_year": "33318.00", "creditors_due_after_one_year": "433119.00", "net_current_assets_liabilities": "431817.00", "total_assets_less_current_liabilities": "431817.00", "net_assets_liabilities": "-1302.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-1303.00", "shareholder_funds": "-1302.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2013.zip" }, { "url": "/company/07133146/accounts/2012-01-31", "pdf_url": "/company/07133146/accounts/2012-01-31.pdf", "made_up_date": "2012-01-31", "period_start": "2012-01-31", "period_end": "2012-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "10591.00", "current_assets": "10591.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-336118.00", "total_assets_less_current_liabilities": "-336118.00", "net_assets_liabilities": "-711921.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-711922.00", "shareholder_funds": "-711921.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2012.zip" }, { "url": "/company/07133146/accounts/2011-01-31", "pdf_url": "/company/07133146/accounts/2011-01-31.pdf", "made_up_date": "2011-01-31", "period_start": "2010-01-22", "period_end": "2011-01-31", "entity_name": "COX Pharmaceutical Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "0.00", "debtors": "0.00", "cash_bank_in_hand": "5412.00", "current_assets": "5412.00", "creditors_due_within_one_year": "623.00", "creditors_due_after_one_year": "9121.00", "net_current_assets_liabilities": "4789.00", "total_assets_less_current_liabilities": "4789.00", "net_assets_liabilities": "-4332.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "-4333.00", "shareholder_funds": "-4332.00", "turnover": "0.00", "other_operating_income": "0.00", "cost_sales": "0.00", "gross_profit_loss": "0.00", "administrative_expenses": "1711.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "-4333.00", "profit_before_tax": "-4333.00", "tax_on_profit": "0.00", "profit_loss_for_period": "-4333.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2011.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07133146/filing-history" }, "confirmation_statement": { "next_due": "2027-08-04", "last_made_up": "2026-07-21" }, "officers": [ { "name": "AL-BAJARI, Ibraheem Abdulazize Ismaeel", "person_url": "/person/6386754", "role": "director", "appointed_on": "2013-09-01", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-23T18:30:03+00:00" }, { "name": "AL-ALLAQ, Taife", "person_url": "/person/6386755", "role": "director", "appointed_on": "2010-03-31", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-07-23T18:30:03+00:00" } ], "psc": [ { "name": "Mr Taife Al-Allaq", "kind": "individual-person-with-significant-control", "person_url": "/person/4925724", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2017-01-01", "ceased_on": null, "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Ibraheem Al-Bajari", "kind": "individual-person-with-significant-control", "person_url": "/person/1983394", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent" ], "notified_on": "2017-01-01", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:43:52.697050+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }